Novavax Aktie

Novavax für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PKMZ / ISIN: US6700024010

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
08.08.2022 22:05:00

Novavax Inc. Q2 Loss increases, misses estimates

(RTTNews) - Novavax Inc. (NVAX) revealed Loss for its second quarter that increased from last year and missed the Street estimates.

The company's earnings came in at -$510.49 million, or -$6.53 per share. This compares with -$352.32 million, or -$4.75 per share, in last year's second quarter.

Analysts on average had expected the company to earn $5.50 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 37.6% to $185.93 million from $298.02 million last year.

Novavax Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$510.49 Mln. vs. -$352.32 Mln. last year. -EPS (Q2): -$6.53 vs. -$4.75 last year. -Analyst Estimate: $5.50 -Revenue (Q2): $185.93 Mln vs. $298.02 Mln last year.

-Guidance: Full year revenue guidance: $2.0 - $2.3 Bln

Analysen zu Novavax Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Novavax Inc. 5,80 -5,91% Novavax Inc.